Serum Protein Profiles to Identify Head and Neck Cancer

Clinical Cancer Research

Volumn 10, Issue 5, 2004, Pages 1625-1632

  Wadsworth, J Trad ^a   Somers, Kenneth D ^a   Cazares, Lisa H ^a,b   Malik, Gunjan ^a,b   Adam, Bao Ling ^a,b   Stack Jr , Brendan C ^c   Wright Jr , George L ^a,b   Semmes, O John ^a,b  

^a EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^b Sentara Cancer Resource Centers   (United States)

^c PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR MARKER;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; EARLY DIAGNOSIS; ETHNOLOGY; FEMALE; GENE EXPRESSION; HEAD AND NECK CANCER; HUMAN; HUMAN TISSUE; MALE; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN MICROARRAY; REPRODUCIBILITY; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; BLOOD PROTEINS; CARCINOMA, SQUAMOUS CELL; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; PROTEIN ARRAY ANALYSIS; REFERENCE VALUES; TUMOR MARKERS, BIOLOGICAL;

EID: 1842481344     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-0297-3     Document Type: Article

References (31)

1. Jemal, A., Murray, T., Samuels, A., Ghafoor, A., Ward, E., and Thun, M., Cancer statistics, 2003. CA - Cancer J. Clin., 53: 5-26, 2003.
2. Smith, R. A., Cokkinides, V., and Eyre, H. J. American Cancer Society guidelines for the early detection of cancer, 2003. CA - Cancer J. Clin., 53: 27-43, 2003.
3. Gleich, L. L., and Salamone, F. N. Molecular genetics of head and neck cancer. Cancer Control, 9: 369-378, 2002.
4. Patel, V., Leethanakul, C., and Gutkind, J. S. New approaches to the understanding of the molecular basis of oral cancer. Crit. Rev. Oral Biol. Med., 12: 55-63, 2001.
5. Srinivas, P. R., Srivastava, S., Hanash, S., and Wright, G. L., Jr. Proteomics in early detection of cancer. Clin. Chem., 47: 1901-1911, 2001.
6. Adam, B. L., Vlahou, A., Semmes, O. J., and Wright, G. L., Jr. Proteomic approaches to biomarker discovery in prostate and bladder cancers. Proteomics, 1: 1264-1270, 2001.
7. Kuwata, H., Yip, T. T., Yip, C. L., Tomita, M., and Hutchens, T. W. Bactericidal domain of lactoferrin: detection, quantitation, and characterization of lactoferricin in serum by SELDI affinity mass spectrometry. Biochem. Biophys. Res. Commun., 245: 764-773, 1998.
8. Merchant, M., and Weinberger, S. R. Recent advancements in surface-enhanced laser desorption/ionization-time of flight-mass spectrometry. Electrophoresis, 21: 1164-1177, 2000.
9. Li, J., Zhang, Z., Rosenzweig, J., Wang, Y. Y., and Chan, D. W. Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer. Clin. Chem., 48: 1296-1304, 2002.
10. Adam, B. L., Qu, Y., Davis, J. W., Ward, M. D., Clements, M. A., Cazares, L. H., Semmes, O. J., Schellhammer, P. F., Yasui, Y., Feng, Z., and Wright, G. L., Jr. Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men. Cancer Res., 62: 3609-3614, 2002.
11. Cazares, L. H., Adam, B. L., Ward, M. D., Nasim, S., Schellhammer, P. F., Semmes, O. J., and Wright, G. L., Jr. Normal, benign, preneoplastic, and malignant prostate cells have distinct protein expression profiles resolved by surface enhanced laser desorption/ionization mass spectrometry. Clin. Cancer Res., 8: 2541-2552, 2002.
12. Petricoin, E. F., Ardekani, A. M., Hitt, B. A., Levine, P. J., Fusaro, V. A., Steinberg, S. M., Mills, G. B., Simone, C., Fishman, D. A., Kohn, E. C., and Liotta, L. A. Use of proteomic patterns in serum to identify ovarian cancer. Lancet, 359: 572-577, 2002.
13. Petricoin, E. F., III, Ornstein, D. K., Paweletz, C. P., Ardekani, A., Hackett, P. S., Hitt, B. A., Velassco, A., Truco, C., Wiegand, L., Wood, K., Simone, C. B., Levine, P. J., Linehan, W. M., Emmert-Buck, M. R., Steinberg, S. M., Kohn, E. C., and Liotta, L. A. Serum proteomic patterns for detection of prostate cancer. J. Natl. Cancer Inst. (Bethesda), 94: 1576-1578, 2002.
14. Vlahou, A., Schellhammer, P. F., Mendrinos, S., Patel, K., Kondylis, F. I., Gong, L., Nasim, S., and Wright, G. L., Jr. Development of a novel proteomic approach for the detection of transitional cell carcinoma of the bladder in urine. Am. J. Pathol., 158: 1491-1502, 2001.
15. Bertone, P., Kluger, Y., Lan, N., Zheng, D., Christendat, D., Yee, A., Edwards, A. M., Arrowsmith, C. H., Montelione, G. T., and Gerstein, M. SPINE: an integrated tracking database and data mining approach for identifying feasible targets in high-throughput structural proteomics. Nucleic Acids Res., 29: 2884-2898, 2001.
16. Kosuda, S., Ichihara, K., Watanabe, M., Kobayashi, H., and Kusano, S. Decision-tree sensitivity analysis for cost-effectiveness of whole-body FDG PET in the management of patients with non-small cell lung carcinoma in Japan. Ann. Nucl. Med., 16: 263-271, 2002.
17. Lin, J. C., Chen, K. Y., Wang, W. Y., Jan, J. S., and Wei, Y. H. PCR detection of circulating tumor cells in nasopharyngeal carcinoma patients with distant metastasis: effect of enzyme and sampling. Head Neck, 24: 591-596, 2002.
18. Dietz, A., Rudat, V., Conradt, C., Weidauer, H., Ho, A., and Moehler, T. Prognostic relevance of serum levels of the angiogenic peptide bFGF in advanced carcinoma of the head and neck treated by primary radiochemotherapy. Head Neck, 22: 666-673, 2000.
19. Walther, E. K., Dahlmann, N., and Gorgulla, H. T. Tumor markers in the diagnosis and follow-up of head and neck cancer: role of CEA, CA 19-9, SCC, TK, and dTTPase. Head Neck, 15: 230-235, 1993.
20. Gottschlich, S., Folz, B. J., Goeroegh, T., Lippert, B. M., Maass, J. D., and Werner, J. A. A new prognostic indicator for head and neck cancer: p53 serum antibodies? Anticancer Res., 19: 2703-2705, 1999.
21. Tavassoli, M., Brunel, N., Maher, R., Johnson, N. W., and Soussi, T. p53 antibodies in the saliva of patients with squamous cell carcinoma of the oral cavity. Int. J. Cancer, 78: 390-391, 1998.
22. Warnakulasuriya, S., Soussi, T., Maher, R., Johnson, N. W., and Tavassoli, M. Expression of p53 in oral squamous cell carcinoma is associated with the presence of IgG and IgA p53 autoantibodies in sera and saliva of the patients. J. Pathol., 192: 52-57, 2000.
23. Nawroz, H., Koch, W., Anker, P., Stroun, M., and Sidransky, D. Microsatellite alterations in serum DNA of head and neck cancer patients. Nat. Med., 2: 1035-1037, 1996.
24. Spafford, M. F., Koch, W. M., Reed, A. L., Califano, J. A., Xu, L. H., Eisenberger, C. F., Yip, L., Leong, P. L., Wu, L., Liu, S. X., Jeronimo, C., Westra, W. H., and Sidransky, D. Detection of head and neck squamous cell carcinoma among exfoliated oral mucosa cells by microsatellite analysis. Clin. Cancer Res., 7: 607-612, 2001.
25. El-Naggar, A. K., Mao, L., Staekel, G., Coombes, M. M., Tucker, S. L., Luna, M. A., Clayman, G. L., Lippman, S., and Goepfert, H. Genetic heterogeneity in saliva from patients with oral squamous carcinomas. Implications in molecular diagnosis and screening. J. Molec. Diagn., 3: 164-170, 2001.
26. Sanchez-Cespedes, M., Esteller, M., Wu, L., Nawroz-Danish, H., Yoo, G. H., Koch, W. M., Jen, J., Herman, J. G., and Sidransky, D. Gene promoter hypermethylation in tumors and serum of head and neck cancer patients. Cancer Res., 60: 892-895, 2000.
27. 6-methylguanine-DNA-methyl transferase, and death associated protein kinase in tumors and saliva of head and neck cancer patients. Cancer Res., 61: 939-942, 2001.
28. von Eggeling, F., Davies, H., Lomas, L., Fiedler, W., Junker, K., Claussen, U., and Ernst, G. Tissue-specific microdissection coupled with ProteinChip array technologies: applications in cancer research. BioTechniques, 29: 1066-1070, 2000.
29. Wu, W., Tang, X., Hu, W., Lotan, R., Hong, W. K., and Mao, L. Identification and validation of metastasis-associated proteins in head and neck cancer cell lines by two-dimensional electrophoresis and mass spectrometry. Clin. Exp. Metastasis, 19: 319-326, 2002.
30. Ries, L. A. G., Eisner, M. P., Kosary, C. L., Hankey, B. F., Miller, B. A., Clegg, L., (eds.). SEER Cancer Statistics Review. Bethesda, MD: NCI, 1975-2000.
31. Breiman, L., Technical note: some properties of splitting criteria. Machine Learning, 26: 123-140, 1996.